Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
A biotechnology company using placental mesenchymal stem cells to develop cell therapies for medical conditions such as inflammation, ischemia, hematological disorders, and radiation.
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
A regenerative medicine company developing biologic products for inflammatory ailments, cardiovascular disease and back pain
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies.
An Australian clinical stage regenerative medicine company founded in 2007 developing cellular therapies based on stem cells and stem cell secretions to treat osteoarthritis, cancer, skin conditions and chronic pain.
TC BioPharm is a biotechnology company developing cell therapies for treating cancer and severe viral infections.
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
Advanced Cell Technology is the previous name of Octa Therapeutics, which is now called Astellas Institute for Regenerative Medicine. The biotechnology company is a subsidiary of Astellas Pharma and was initially focused on the development of regenerative opthalmology therapeutics using stem cells.
Alliance for Regenerative Medicine (ARM) is an international community of therapeutics companies, non-profit research institutes, and patient organizations advocating for regenerative medicines.
Exopharm is a regenerative medicine biopharmaceutical company spun out of Altnia Group. Founded in 2003 and based in Melbourne, Australia, the company aims to develop and commercialize exosomes as therapeutic agents.
Regenerative medicine company that is a subsidiary of Astellas Pharma focused on development and commercialization of stem cell and regenerative medicine therapies.
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
Prellis Biologics is developing technology to build transplantable human organs and tissues.
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
A biopharmaceutical company developing therapeutic products for the treatment of diseases.
Capricor Therapeutics is a biotechnology company developing biological treatments for rare health disorders.
The Regeneration Center is a biotechnology company developing Functional & Regenerative Medical therapies
Celuarity is a commercial stage cellular therapeutic company focusing on allogenic cellular therapies.